Talk:Talisa: Difference between revisions
Jump to navigation
Jump to search
Dridhabala (talk | contribs) No edit summary |
Dridhabala (talk | contribs) No edit summary |
||
| Line 29: | Line 29: | ||
}} | }} | ||
'''Talisapatra''' (Latin: ''Abies webbiana'' Lindl., synonym: ''Abies spectabilis'' (D.Don) Spach; family: Pinaceae) is a lofty, evergreen coniferous tree native to the high-altitude Himalayan belt. In [[Ayurveda]], its aromatic leaves are regarded as a premier natural expectorant, bronchodilator, carminative, and Kapha-Vata pacifying medicine, famously constituting the primary bio-enhancer and botanical cornerstone of ''Talisadi Churna''.<ref name=" | '''Talisapatra''' (Latin: ''Abies webbiana'' Lindl., synonym: ''Abies spectabilis'' (D.Don) Spach; family: Pinaceae) is a lofty, evergreen coniferous tree native to the high-altitude Himalayan belt. In [[Ayurveda]], its aromatic leaves are regarded as a premier natural expectorant, bronchodilator, carminative, and Kapha-Vata pacifying medicine, famously constituting the primary bio-enhancer and botanical cornerstone of ''Talisadi Churna''.<ref name="API">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |volume=4 |pages=58–59 |edition=Part I}}</ref> | ||
== Botanical & Vernacular Names == | == Botanical & Vernacular Names == | ||
| Line 42: | Line 42: | ||
== Synonyms in Classical Texts == | == Synonyms in Classical Texts == | ||
* '''Synonyms in Bhavaprakasha Nighantu:'''<ref name=" | * '''Synonyms in Bhavaprakasha Nighantu:'''<ref name="Bhavaprakash">{{cite book |last=Chunekar |first=K. C. |title=Bhavaprakash Nighantu |year=2020 |publisher=Chaukhambha Bharati Academy |pages=Karpuradi varga, verse 114 |edition=Reprint}}</ref> | ||
** ''Talisa'' – Traditional designation. | ** ''Talisa'' – Traditional designation. | ||
** ''Patradhya'' – Characterized by dense, abundant, and prominent foliage. | ** ''Patradhya'' – Characterized by dense, abundant, and prominent foliage. | ||
| Line 51: | Line 51: | ||
== Ayurvedic Pharmacological Properties == | == Ayurvedic Pharmacological Properties == | ||
According to classical Ayurvedic pharmacodynamics (''Rasa Panchaka''), Talisapatra possesses hot potency and lightness, making it particularly potent in counteracting obstructive mucus and cold imbalances:<ref name=" | According to classical Ayurvedic pharmacodynamics (''Rasa Panchaka''), Talisapatra possesses hot potency and lightness, making it particularly potent in counteracting obstructive mucus and cold imbalances:<ref name="API" /> | ||
{| class="wikitable sortable" style="text-align:left;" | {| class="wikitable sortable" style="text-align:left;" | ||
| Line 85: | Line 85: | ||
== Therapeutic Indications (Classical) == | == Therapeutic Indications (Classical) == | ||
Bhumipatra/Talisapatra is traditionally indicated in the clinical management of:<ref name=" | Bhumipatra/Talisapatra is traditionally indicated in the clinical management of:<ref name="API" /> | ||
* ''Kasa'' (Cough / Bronchitis / Tracheitis) | * ''Kasa'' (Cough / Bronchitis / Tracheitis) | ||
* ''Swasa'' (Dyspnea / Asthma / COPD) | * ''Swasa'' (Dyspnea / Asthma / COPD) | ||
| Line 98: | Line 98: | ||
== Dosage & Administration == | == Dosage & Administration == | ||
* '''Powder (''Churna''):''' 2 – 3 g of the purified, dried leaf powder daily in divided doses, traditionally combined with raw honey or warm water.<ref name=" | * '''Powder (''Churna''):''' 2 – 3 g of the purified, dried leaf powder daily in divided doses, traditionally combined with raw honey or warm water.<ref name="API" /> | ||
== Classical Formulations == | == Classical Formulations == | ||
| Line 122: | Line 122: | ||
Classical Ayurveda classifies Talisa as a drug of choice for respiratory constriction (''Swasahara''). | Classical Ayurveda classifies Talisa as a drug of choice for respiratory constriction (''Swasahara''). | ||
* '''Mechanism:''' The lipophilic leaf extracts elicit smooth muscle relaxation by functioning as a functional antagonist against calcium mobilization, disrupting voltage-dependent calcium entry pathways in airway smooth muscle. | * '''Mechanism:''' The lipophilic leaf extracts elicit smooth muscle relaxation by functioning as a functional antagonist against calcium mobilization, disrupting voltage-dependent calcium entry pathways in airway smooth muscle. | ||
* '''Scientific Evidence:''' Isolated tissue bath experiments demonstrated that crude extracts of ''A. webbiana'' completely relaxed carbachol- and potassium chloride ($K^+$)-induced contractions in isolated rabbit tracheal preparations in a concentration-dependent manner, confirming an efficacy comparable to standard calcium-channel blockers like verapamil.<ref name=" | * '''Scientific Evidence:''' Isolated tissue bath experiments demonstrated that crude extracts of ''A. webbiana'' completely relaxed carbachol- and potassium chloride ($K^+$)-induced contractions in isolated rabbit tracheal preparations in a concentration-dependent manner, confirming an efficacy comparable to standard calcium-channel blockers like verapamil.<ref name="Ghayur">{{cite journal |last1=Ghayur |first1=M. N. |last2=Gilani |first2=A. H. |last3=Janssen |first3=L. J. |year=2007 |title=Antispasmodic, bronchodilator and anti-platelet activities of Abies webbiana |journal=Phytotherapy Research |volume=21 |issue=8 |pages=754–759 |doi=10.1002/ptr.2155}}</ref> | ||
==== Antitussive & Mast Cell-Stabilizing Efficacy ==== | ==== Antitussive & Mast Cell-Stabilizing Efficacy ==== | ||
* '''Mechanism:''' Volatile terpenes and polyphenols inhibit neurogenic peripheral sensory afferents in the trachea and inhibit degranulation of tissue mast cells. | * '''Mechanism:''' Volatile terpenes and polyphenols inhibit neurogenic peripheral sensory afferents in the trachea and inhibit degranulation of tissue mast cells. | ||
* '''Scientific Evidence:''' In animal models of chemical cough challenge, oral administration of methanol extracts of ''A. webbiana'' leaves (400 mg/kg and 600 mg/kg body weight) produced substantial, dose-dependent reductions in sulfur dioxide ($SO_2$)-induced cough reflex, displaying up to 78.67% inhibition—a profile matching standard codeine phosphate.<ref name=" | * '''Scientific Evidence:''' In animal models of chemical cough challenge, oral administration of methanol extracts of ''A. webbiana'' leaves (400 mg/kg and 600 mg/kg body weight) produced substantial, dose-dependent reductions in sulfur dioxide ($SO_2$)-induced cough reflex, displaying up to 78.67% inhibition—a profile matching standard codeine phosphate.<ref name="Nayampalli">{{cite journal |last1=Nayampalli |first1=S. |last2=Desai |first2=N. K. |last3=Ainapure |first3=S. S. |year=1998 |title=Antitussive activity of Abies webbiana leaves |journal=Indian Journal of Pharmacology |volume=30 |issue=5 |pages=340–342}}</ref> The plant also exhibits notable compound 48/80-induced peritoneal mast cell-stabilizing properties. | ||
==== Anti-Inflammatory & Analgesic Actions ==== | ==== Anti-Inflammatory & Analgesic Actions ==== | ||
* '''Mechanism:''' Flavonoids like abiesin and associated polyphenols curb prostaglandin synthesis by attenuating the activity of cyclooxygenase-2 (COX-2) and diminishing neutrophil extravasation into inflamed beds. | * '''Mechanism:''' Flavonoids like abiesin and associated polyphenols curb prostaglandin synthesis by attenuating the activity of cyclooxygenase-2 (COX-2) and diminishing neutrophil extravasation into inflamed beds. | ||
* '''Scientific Evidence:''' In carrageenan-induced rat paw edema testing, methanolic leaf extracts (200–400 mg/kg) caused significant and sustained reductions in edema volumes comparable to standard non-steroidal anti-inflammatory drugs (diclofenac sodium at 150 mg/kg).<ref name=" | * '''Scientific Evidence:''' In carrageenan-induced rat paw edema testing, methanolic leaf extracts (200–400 mg/kg) caused significant and sustained reductions in edema volumes comparable to standard non-steroidal anti-inflammatory drugs (diclofenac sodium at 150 mg/kg).<ref name="Viswanathan">{{cite journal |last1=Viswanathan |first1=S. |last2=Thirugnanasambantham |first2=P. |last3=Kannan |first3=R. |last4=Reddy |first4=C. |year=2004 |title=Anti-inflammatory and antipyretic activities of Abies webbiana Lindl. |journal=Pharmacologyonline |volume=2 |pages=152–158}}</ref> | ||
==== Broad-Spectrum Antimicrobial & Antifungal Activity ==== | ==== Broad-Spectrum Antimicrobial & Antifungal Activity ==== | ||
* '''Mechanism:''' Monoterpenes present in the essential oil (α-pinene, limonene) disrupt microbial outer membranes and interfere with cell-wall bio-integrity. | * '''Mechanism:''' Monoterpenes present in the essential oil (α-pinene, limonene) disrupt microbial outer membranes and interfere with cell-wall bio-integrity. | ||
* '''Scientific Evidence:''' In vitro disk and agar-well diffusion assays showed pronounced inhibitory activity against key upper respiratory pathogens, with the greatest growth inhibition observed against ''Staphylococcus aureus'', ''Salmonella typhi'', ''Bacillus subtilis'', and the fungal strain ''Candida albicans''.<ref name=" | * '''Scientific Evidence:''' In vitro disk and agar-well diffusion assays showed pronounced inhibitory activity against key upper respiratory pathogens, with the greatest growth inhibition observed against ''Staphylococcus aureus'', ''Salmonella typhi'', ''Bacillus subtilis'', and the fungal strain ''Candida albicans''.<ref name="Singh">{{cite journal |last1=Singh |first1=R. |last2=Chauhan |first2=S. |last3=Grover |first3=G. |year=2013 |title=In vitro antimicrobial evaluation of Abies webbiana leaves against pathogenic strains |journal=International Journal of Pharmaceutical Sciences and Research |volume=4 |issue=9 |pages=3545–3549}}</ref> | ||
==== Anti-Platelet Aggregation Action ==== | ==== Anti-Platelet Aggregation Action ==== | ||
* '''Mechanism:''' Constituents modulate surface receptor affinity on thrombocytes, suppressing activation pathways mediated by adenosine diphosphate (ADP) and catecholamines. | * '''Mechanism:''' Constituents modulate surface receptor affinity on thrombocytes, suppressing activation pathways mediated by adenosine diphosphate (ADP) and catecholamines. | ||
* '''Scientific Evidence:''' Crude extracts demonstrated clear in vitro inhibition of human platelet aggregation provoked by ADP and epinephrine, supporting classical records regarding its cardioprotective (''Hrudya'') and vascular-stabilizing qualities.<ref name=" | * '''Scientific Evidence:''' Crude extracts demonstrated clear in vitro inhibition of human platelet aggregation provoked by ADP and epinephrine, supporting classical records regarding its cardioprotective (''Hrudya'') and vascular-stabilizing qualities.<ref name="Ghayur" /> | ||
==== Neuropharmacological & Anxiolytic Effects ==== | ==== Neuropharmacological & Anxiolytic Effects ==== | ||
* '''Mechanism:''' Nitrogenous components and volatile terpenes potentiate gamma-aminobutyric acid (GABA)-ergic neurotransmission in the central nervous system. | * '''Mechanism:''' Nitrogenous components and volatile terpenes potentiate gamma-aminobutyric acid (GABA)-ergic neurotransmission in the central nervous system. | ||
* '''Scientific Evidence:''' Using the elevated plus-maze (EPM) and light/dark transition paradigm in rodents, polar extracts displayed significant central anxiolytic, mild sedative, and muscle-relaxant actions without inducing neurotoxic deficits or acute motor ataxia.<ref name=" | * '''Scientific Evidence:''' Using the elevated plus-maze (EPM) and light/dark transition paradigm in rodents, polar extracts displayed significant central anxiolytic, mild sedative, and muscle-relaxant actions without inducing neurotoxic deficits or acute motor ataxia.<ref name="Gupta">{{cite journal |last1=Gupta |first1=R. |last2=Dixit |first2=V. K. |year=2008 |title=Neuropharmacological actions of Abies webbiana Lindl. leaf extracts |journal=Journal of Natural Medicines |volume=62 |issue=3 |pages=308–313 |doi=10.1007/s11418-008-0238-z}}</ref> | ||
== Safety & Toxicity Profile == | == Safety & Toxicity Profile == | ||
| Line 150: | Line 150: | ||
== References == | == References == | ||
{{Reflist|refs= | {{Reflist|refs= | ||
<ref name=" | <ref name="API">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |volume=4 |pages=58–59 |edition=Part I}}</ref> | ||
<ref name=" | <ref name="Bhavaprakash">{{cite book |last=Chunekar |first=K. C. |title=Bhavaprakash Nighantu |year=2020 |publisher=Chaukhambha Bharati Academy |pages=Karpuradi varga, verse 114 |edition=Reprint}}</ref> | ||
<ref name="Ghayur">{{cite journal |last1=Ghayur |first1=M. N. |last2=Gilani |first2=A. H. |last3=Janssen |first3=L. J. |year=2007 |title=Antispasmodic, bronchodilator and anti-platelet activities of Abies webbiana |journal=Phytotherapy Research |volume=21 |issue=8 |pages=754–759 |doi=10.1002/ptr.2155}}</ref> | |||
<ref name="Nayampalli">{{cite journal |last1=Nayampalli |first1=S. |last2=Desai |first2=N. K. |last3=Ainapure |first3=S. S. |year=1998 |title=Antitussive activity of Abies webbiana leaves |journal=Indian Journal of Pharmacology |volume=30 |issue=5 |pages=340–342}}</ref> | |||
<ref name="Viswanathan">{{cite journal |last1=Viswanathan |first1=S. |last2=Thirugnanasambantham |first2=P. |last3=Kannan |first3=R. |last4=Reddy |first4=C. |year=2004 |title=Anti-inflammatory and antipyretic activities of Abies webbiana Lindl. |journal=Pharmacologyonline |volume=2 |pages=152–158}}</ref> | |||
<ref name=" | <ref name="Singh">{{cite journal |last1=Singh |first1=R. |last2=Chauhan |first2=S. |last3=Grover |first3=G. |year=2013 |title=In vitro antimicrobial evaluation of Abies webbiana leaves against pathogenic strains |journal=International Journal of Pharmaceutical Sciences and Research |volume=4 |issue=9 |pages=3545–3549}}</ref> | ||
<ref name=" | <ref name="Gupta">{{cite journal |last1=Gupta |first1=R. |last2=Dixit |first2=V. K. |year=2008 |title=Neuropharmacological actions of Abies webbiana Lindl. leaf extracts |journal=Journal of Natural Medicines |volume=62 |issue=3 |pages=308–313 |doi=10.1007/s11418-008-0238-z}}</ref> | ||
<ref name=" | |||
<ref name=" | |||
<ref name=" | |||
}} | }} | ||
Revision as of 05:10, 10 September 2026
| Section/Chapter | Herb database/Talisa |
|---|---|
| Botanical name(s) | Abies webbiana Lindl. |
| Family | Pinaceae |
| Availability | Available |
| Contributors | Team Dravyaguna |
| Year of publication | 2026 |
| Publisher | Charak Samhita Research, Training and Skill Development Centre |
| DOI | Awaited |
Talisapatra (Latin: Abies webbiana Lindl., synonym: Abies spectabilis (D.Don) Spach; family: Pinaceae) is a lofty, evergreen coniferous tree native to the high-altitude Himalayan belt. In Ayurveda, its aromatic leaves are regarded as a premier natural expectorant, bronchodilator, carminative, and Kapha-Vata pacifying medicine, famously constituting the primary bio-enhancer and botanical cornerstone of Talisadi Churna.[1]
Botanical & Vernacular Names
- Botanical Name: Abies webbiana Lindl. / Abies spectabilis (D.Don) Spach
- Family: Pinaceae (Coniferae)
- English Names: Himalayan silver fir, East Himalayan fir, Indian silver fir
- Sanskrit / Classical Names: Talisapatra, Talisa, Patradhya
- Hindi: Talispatra, Chilrow
- Bengali: Talishpatra, Talish
- Tamil: Talisapatri
- Telugu: Taleesapatri
Synonyms in Classical Texts
- Synonyms in Bhavaprakasha Nighantu:[2]
- Talisa – Traditional designation.
- Patradhya – Characterized by dense, abundant, and prominent foliage.
- Dhatripatra – Pectinate leaf arrangement resembling the feathery foliage of Amalaki (Phyllanthus emblica).
- Madhurapatra – Leaves possessing an intrinsically faint sweet aftertaste.
Ayurvedic Pharmacological Properties
According to classical Ayurvedic pharmacodynamics (Rasa Panchaka), Talisapatra possesses hot potency and lightness, making it particularly potent in counteracting obstructive mucus and cold imbalances:[1]
| Sr. No. | Pharmacological Criteria | Properties (Ayurvedic Attributes) |
|---|---|---|
| 1 | Taste (Rasa) | Sweet (Madhura), Bitter (Tikta), Pungent (Katu) |
| 2 | Potency (Veerya) | Hot (Ushna) |
| 3 | Post-digestion Effect (Vipaka) | Pungent (Katu) |
| 4 | Qualities (Guna) | Light (Laghu), Sharp / Penetrating (Tikshna) |
| 5 | Dosha Action (Karma) | Pacifies Kapha and Vata (Kapha-Vatahara) |
| 6 | Specific Actions (Karma) | Expectorant and anti-tussive (Kasahara), Bronchodilatory (Swasahara), Digestive stimulant (Deepana), Heart congenial / Cardiotonic (Hrudya), Carminative (Vatanulomana) |
References in Charaka Samhita
Talisapatra is documented in several therapeutic yogas (formulations) within the Charaka Samhita:
| Sr. No. | Reference in Charak Samhita | Context / Formulation / Application |
|---|---|---|
| 1 | Cha.Sa.Sharira Sthana 8/41 | Indicated in fumigation and therapeutic pastes during post-delivery management for placenta expulsion (Apara Patana) |
| 2 | Cha.Sa.Chikitsa Sthana 17/143 | Compounded in Tejovatyadi Ghrita for dyspnea and cough |
| 3 | Cha.Sa.Chikitsa Sthana 26/192 | Formulated as an ingredient in Kalaka Churna for throat and oral afflictions |
| 4 | Cha.Sa.Chikitsa Sthana 27/30 | Used as an adjuvant aromatic formulation herb (Yoga Dravya) in gastrointestinal and systemic vata disorders |
Therapeutic Indications (Classical)
Bhumipatra/Talisapatra is traditionally indicated in the clinical management of:[1]
- Kasa (Cough / Bronchitis / Tracheitis)
- Swasa (Dyspnea / Asthma / COPD)
- Hikka (Hiccups)
- Agnimandhya & Aruchi (Hypochlorhydria / Anorexia / Loss of taste)
- Amadosha (Metabolic endotoxemia / Impaired digestion)
- Gulma (Abdominal diverticula / Phantom tumors)
- Kshaya (Phthisis / Chronic pulmonary debility / Wasting disease)
- Chardi (Vomiting / Emesis)
- Krumi (Intestinal parasites / Helminthiasis)
- Mukharoga (Periodontal infections / Disorders of the buccal cavity)
Dosage & Administration
- Powder (Churna): 2 – 3 g of the purified, dried leaf powder daily in divided doses, traditionally combined with raw honey or warm water.[1]
Classical Formulations
- Talisadi Churna
- Talisadi Modaka
- Drakshadi Churna
- Bhaskara Lavana
- Pranada Gutika
- Jatiphaladi Churna
- Puga Khanda
Current Researches
Phytochemical Composition
Phytochemical investigations have shown that the bioactivity of Abies webbiana leaves is derived from a complex matrix of essential monoterpenes, biflavonoids, and unique alkaloids:
- Essential Oil (0.5%–1.2%): Dominated by monoterpenes and sesquiterpenes including α-pinene, β-pinene, limonene, camphene, bornyl acetate, car-3-ene, and α-terpinolene.
- Biflavonoids & Glycosides: Bioflavonoids such as **Abiesin** (5,3″,7″-trihydroxy-7,4′,4‴-trimethoxy-(3′,6″)-biflavone), betuloside, and methylquercetin derivatives.
- Alkaloids & Nitrogenous Moieties: Isolation of unique natural products including **1-(4'-methoxyphenyl)-aziridine**.
- Terpenoids & Sterols: β-sitosterol, lupeol, ursolic acid derivatives, and taxoid-free diterpene glycosides.
Pharmacological Activities & Therapeutic Efficacy
Bronchodilator & Antispasmodic Activity
Classical Ayurveda classifies Talisa as a drug of choice for respiratory constriction (Swasahara).
- Mechanism: The lipophilic leaf extracts elicit smooth muscle relaxation by functioning as a functional antagonist against calcium mobilization, disrupting voltage-dependent calcium entry pathways in airway smooth muscle.
- Scientific Evidence: Isolated tissue bath experiments demonstrated that crude extracts of A. webbiana completely relaxed carbachol- and potassium chloride ($K^+$)-induced contractions in isolated rabbit tracheal preparations in a concentration-dependent manner, confirming an efficacy comparable to standard calcium-channel blockers like verapamil.[3]
Antitussive & Mast Cell-Stabilizing Efficacy
- Mechanism: Volatile terpenes and polyphenols inhibit neurogenic peripheral sensory afferents in the trachea and inhibit degranulation of tissue mast cells.
- Scientific Evidence: In animal models of chemical cough challenge, oral administration of methanol extracts of A. webbiana leaves (400 mg/kg and 600 mg/kg body weight) produced substantial, dose-dependent reductions in sulfur dioxide ($SO_2$)-induced cough reflex, displaying up to 78.67% inhibition—a profile matching standard codeine phosphate.[4] The plant also exhibits notable compound 48/80-induced peritoneal mast cell-stabilizing properties.
Anti-Inflammatory & Analgesic Actions
- Mechanism: Flavonoids like abiesin and associated polyphenols curb prostaglandin synthesis by attenuating the activity of cyclooxygenase-2 (COX-2) and diminishing neutrophil extravasation into inflamed beds.
- Scientific Evidence: In carrageenan-induced rat paw edema testing, methanolic leaf extracts (200–400 mg/kg) caused significant and sustained reductions in edema volumes comparable to standard non-steroidal anti-inflammatory drugs (diclofenac sodium at 150 mg/kg).[5]
Broad-Spectrum Antimicrobial & Antifungal Activity
- Mechanism: Monoterpenes present in the essential oil (α-pinene, limonene) disrupt microbial outer membranes and interfere with cell-wall bio-integrity.
- Scientific Evidence: In vitro disk and agar-well diffusion assays showed pronounced inhibitory activity against key upper respiratory pathogens, with the greatest growth inhibition observed against Staphylococcus aureus, Salmonella typhi, Bacillus subtilis, and the fungal strain Candida albicans.[6]
Anti-Platelet Aggregation Action
- Mechanism: Constituents modulate surface receptor affinity on thrombocytes, suppressing activation pathways mediated by adenosine diphosphate (ADP) and catecholamines.
- Scientific Evidence: Crude extracts demonstrated clear in vitro inhibition of human platelet aggregation provoked by ADP and epinephrine, supporting classical records regarding its cardioprotective (Hrudya) and vascular-stabilizing qualities.[3]
Neuropharmacological & Anxiolytic Effects
- Mechanism: Nitrogenous components and volatile terpenes potentiate gamma-aminobutyric acid (GABA)-ergic neurotransmission in the central nervous system.
- Scientific Evidence: Using the elevated plus-maze (EPM) and light/dark transition paradigm in rodents, polar extracts displayed significant central anxiolytic, mild sedative, and muscle-relaxant actions without inducing neurotoxic deficits or acute motor ataxia.[7]
Safety & Toxicity Profile
- Acute Toxicity: Animal toxicity screens demonstrate wide therapeutic margins. Median lethal dose ($LD_{50}$) assays for polar leaf extracts exceed 1,000–1,500 mg/kg p.o. in mice and rats, placing normal therapeutic intakes (2–3 g dried powder/day) well within safety thresholds.
- Adverse Effects & Precautions: Because of its pungent post-digestive effect (Katu Vipaka) and hot potency (Ushna Veerya), excessive dosing may aggravate Pitta dosha, manifesting as heartburn, pyrosis, or gastric irritation in individuals with active peptic ulcers.
References
- ↑ 1.0 1.1 1.2 1.3 The Ayurvedic Pharmacopoeia of India. 4 (Part I ed.). Department of Ayush, Ministry of Health and Family Welfare, Govt. of India. 1986. pp. 58–59.
- ↑ Chunekar, K. C. (2020). Bhavaprakash Nighantu (Reprint ed.). Chaukhambha Bharati Academy. pp. Karpuradi varga, verse 114.
- ↑ 3.0 3.1 Ghayur, M. N.; Gilani, A. H.; Janssen, L. J. (2007). "Antispasmodic, bronchodilator and anti-platelet activities of Abies webbiana". Phytotherapy Research. 21 (8): 754–759. doi:10.1002/ptr.2155.
- ↑ Nayampalli, S.; Desai, N. K.; Ainapure, S. S. (1998). "Antitussive activity of Abies webbiana leaves". Indian Journal of Pharmacology. 30 (5): 340–342.
- ↑ Viswanathan, S.; Thirugnanasambantham, P.; Kannan, R.; Reddy, C. (2004). "Anti-inflammatory and antipyretic activities of Abies webbiana Lindl.". Pharmacologyonline. 2: 152–158.
- ↑ Singh, R.; Chauhan, S.; Grover, G. (2013). "In vitro antimicrobial evaluation of Abies webbiana leaves against pathogenic strains". International Journal of Pharmaceutical Sciences and Research. 4 (9): 3545–3549.
- ↑ Gupta, R.; Dixit, V. K. (2008). "Neuropharmacological actions of Abies webbiana Lindl. leaf extracts". Journal of Natural Medicines. 62 (3): 308–313. doi:10.1007/s11418-008-0238-z.